Well, you have to give me credit for being consistent.
Years ago, I balked at adding thermal pulsatile treatment using LipiFlow (now owned by Johnson & Johnson Vision) because I hated the early business model so much. Once the good folks at TearScience made a few changes (that I may or may not have suggested), even the attempted panel ambush at Caribbean Eye was not enough to scare me off. The science was good, and LipiFlow (as well as meibomian gland imaging and tear lipid analysis) has performed as predicted. (Read more...)
Uncategorized